The UK Health Security Agency (UKHSA) provided a significant update on the ongoing meningitis outbreak in Kent. According to the latest information, there have been no new instances of meningitis reported in the past 24 hours. However, investigations are still underway regarding the outbreak of meningococcal disease in Kent.
As of 12:30 pm on March 22, there have been 20 confirmed cases identified through laboratory testing, with 9 additional cases under investigation, bringing the total to 29 cases. This follows the tragic deaths of two individuals earlier this month, which were linked to an outbreak associated with Club Chemistry nightclub in Canterbury.
Dr. Sherine Thomas, an Infectious Diseases Consultant at UKHSA, emphasized the agency’s continued vigilance in monitoring for new cases and maintaining close collaboration with NHS England and local authorities nationwide. She expressed appreciation for the proactive response from eligible individuals who have sought antibiotics and vaccinations. Dr. Thomas stressed the importance of awareness about the symptoms of invasive meningococcal disease and urged prompt medical attention for anyone experiencing these symptoms or knowing someone who is.
The number of suspected cases under investigation has decreased from 11 to nine, resulting in a total of 29 cases, down from 34 previously reported. Among the confirmed cases, 19 are identified as meningitis B, all of which have required hospitalization.
A suspected case has been linked to another educational institution in Kent, aside from the University of Kent. The East Kent Colleges (EKC) Group informed parents and carers about a student receiving treatment for a suspected meningitis case. Efforts to administer the menB vaccine and antibiotics have seen a decline in the number of people lining up across the county, with expectations of further reductions in cases as additional laboratory analyses are completed.
Tragically, among the casualties are two students, including 18-year-old Juliette, who was described as healthy and strong before her sudden illness. Juliette’s family shared the heartbreaking account of her rapid decline, with symptoms initially manifesting as vomiting and cheek discoloration. Despite swift medical intervention, Juliette succumbed to meningitis within hours of showing symptoms.
Vinny Smith, the chief executive of Meningitis Research Foundation, highlighted past advocacy efforts for routine menB vaccination within at-risk age groups on the NHS, which were not implemented due to cost-effectiveness considerations.
